What does ESTRO stand for?

European Society for Therapeutic Radiology and Oncology

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.
Organizations, NGOs, schools, universities, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
European Small Town Poker Tour Electronic Standard Time Report (payroll software; University of Illinois) Engineering Science Tape Recorder Estrada (Portuguese: road; postal usage) Étude Service Technique Réfrigération (French: Study Technical Service Refrigeration) Expanded Simple Tandem Repeat (cells) Empire State Towing and Recovery Association (Albany, NY) European Space Tracking (Network) Environmental Security Technology Requirements Group Electronic Standards for the Transmission of Regulatory Information		École Supérieure de Technologie de Salé (French: School of Technology Sale; Sale, Morocco) Electric Ship Technologies Symposium Electronic Systems Test Set Elementary Student Talent Search Energy Science and Technology Software Estates (US Postal service standard street suffix) European Society of Thoracic Surgeons Energy Science and Technology Software Center Electronic Systems Test Set Group Eternal Sunshine of the Spotless Mind (movie)

Samples in periodicals archive:

Compact Particle Acceleration Corporation (CPAC) today announced that it introduced its state-of-the-art compact proton therapy program, featuring a dielectric-wall accelerator (DWA), during the European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting that concluded today in Gothenburg, Sweden.

CPAC Highlights its Proton Therapy Program at ESTRO Annual Meeting

The Advanced Clinical Solutions Symposium was hosted by TomoTherapy Incorporated (NASDAQ: TOMO), maker of the HioArt([R]) treatment system, and held during the European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting.

Cancer Treatment Specialists Highlight Clinical Benefits, Expanded ...

NASDAQ: OXGN, XSSE: OXGN) announced today that new data demonstrating anti-tumor activity of the Company's lead drug candidate, CA4P, in combination with radiotherapy, will be presented at the European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Amsterdam held October 24th through the 28th.

OXiGENE's Lead Drug Candidate CA4P Demonstrates Anti-tumor Activity ...